Business
GSK profit lifted by HIV, asthma drugs in boost to new CEO
Its adjusted earnings per share rises to 25.5 pence, higher than analysts’ expectations reported better-than-expected profit in the fourth…
Tag
GSK
Business
GSK plans £2 billion share buyback, boosts long-term outlook
GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism around its drug pipeline.…
Business
GSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion…